Serviço de Cirurgia Cardíaca em Adultos, Onassis Cardiac Surgery Center - Atenas, Grécia.
Serviço de Cardiologia, Hippokration Hospital, University of Athens - Atenas, Grécia.
Rev Bras Ter Intensiva. 2020 Oct-Dec;32(4):542-550. doi: 10.5935/0103-507X.20200091.
To assess whether preoperative versus intraoperative insertion of an intra-aortic balloon pump is associated with lower 30-day mortality or reduced length of hospital stay among patients who had an intra-aortic balloon pump inserted for cardiac surgery.
This was an observational study of patients who had an intra-aortic balloon pump inserted in the preoperative or intraoperative period of cardiac surgery in our department between 2000 and 2012. We assessed the association between preoperative versus intraoperative insertion of an intra-aortic balloon pump and 30-day mortality in a multivariable logistic regression analysis, including preoperative New York Heart Association class, postoperative atrial fibrillation, reoperation, postoperative creatinine and isolated coronary bypass grafting as cofactors. We used a multivariate linear model to assess whether a preoperative versus intraoperative intra-aortic balloon pump was associated with length of postoperative hospital stay, adjusting for reoperation, isolated coronary bypass grafting, heart valve surgery, sex, age, cardiopulmonary bypass time, aortic cross-clamp time, preoperative patients' status (elective, urgency or emergency surgery) and preoperative myocardial infarction.
Overall, 7,540 consecutive patients underwent open heart surgery in our department, and an intra-aortic balloon pump was inserted pre- or intraoperatively in 322 (4.2%) patients. The mean age was 67 ± 10.2 years old, the 30-day mortality was 12.7%, and the median length of hospital stay was 9 days (7 - 13). Preoperative versus intraoperative intra-aortic balloon pump insertion did not affect the incidence of 30-day mortality (adjusted OR = 0.69; 95% CI, 0.15 - 3.12; p = 0.63) and length of postoperative hospital stay (β = 5.3; 95%CI, -1.6 to 12.8; p = 0.13).
Preoperative insertion of an intra-aortic balloon pump was not associated with a lower 30-day mortality or reduced length of postoperative hospital stay compared to intraoperative insertion.
评估在心脏手术中,与术中相比,术前放置主动脉内球囊反搏泵是否与较低的 30 天死亡率或住院时间缩短相关。
这是一项观察性研究,研究对象为 2000 年至 2012 年期间在我院心脏手术的术前或术中介入主动脉内球囊反搏泵的患者。我们在多变量逻辑回归分析中评估了术前与术中放置主动脉内球囊反搏泵与 30 天死亡率之间的关系,包括术前纽约心脏协会(NYHA)分级、术后心房颤动、再次手术、术后肌酐和单纯冠状动脉旁路移植术作为协变量。我们使用多元线性模型来评估术前与术中主动脉内球囊反搏泵与术后住院时间的关系,调整再次手术、单纯冠状动脉旁路移植术、心脏瓣膜手术、性别、年龄、体外循环时间、主动脉阻断时间、术前患者状态(择期、紧急或急诊手术)和术前心肌梗死。
总体而言,我院连续进行了 7540 例心脏手术,322 例(4.2%)患者在术前或术中介入了主动脉内球囊反搏泵。患者平均年龄为 67 ± 10.2 岁,30 天死亡率为 12.7%,中位住院时间为 9 天(7-13 天)。与术中相比,术前放置主动脉内球囊反搏泵并不影响 30 天死亡率(调整后的 OR = 0.69;95%CI,0.15-3.12;p = 0.63)和术后住院时间(β=5.3;95%CI,-1.6 至 12.8;p = 0.13)。
与术中相比,术前放置主动脉内球囊反搏泵与较低的 30 天死亡率或术后住院时间缩短无关。